BCL2 and cancer: Mechanistically, RVS downregulates the ATF4/Chop/BCL-2/BAX signaling pathway, contributing to anti-aging and anti-cancer effects [167] and synergistic effects with agents like prednisolone enhance apoptosis through BAX and BCL-2 modulation [168].